Adjust expands advisory proposition with acquisition of Accent Advies
Amsterdam, December 22nd 2025 – Our portfolio company Adjust Consulting (Adjust) is expanding its advisory proposition with the acquisition of Accent Advies. This transaction strengthens Adjust’s position in control, risk management and audit, and further reinforces its presence in the semi-public sector and the housing corporation sector.
Guido Winnink, CEO of Adjust: “The acquisition of Accent Advies is a valuable addition to our service offering in a domain and sector where we already have a strong position. The expertise, experience and capabilities of Accent Advies will enable us to support our clients even better in addressing complex challenges in control, risk management and audit.”
Marc Breij, on behalf of Accent Advies: “By joining Adjust, we can offer our clients a broader and more comprehensive range of services. At the same time, we become part of a growing organization, allowing us to further strengthen our organization together, for the benefit of our clients and our own development.”
Since becoming a shareholder in 2024, Holland Capital has actively supported Adjust in its operational and strategic development. The collaboration with Accent Advies aligns with Adjust’s buy-and-build strategy.
About Accent Advies
Accent Advies is a specialized advisory firm focusing on integrated risk management, governance, internal audit, process optimization, and strengthening organizational and governance models. The firm is led by Marc Breij, Frank van Egeraat and Sander Boelen, and works with a team of associates.
About Adjust
Founded in 2003, Adjust is a leading advisory firm in the Netherlands specializing in procurement and contract management. At Adjust, people and clients come first: consultants work with passion, integrity and dedication, always striving to balance commercial success with societal impact. Adjust has won the FD Gazellen Award ten times and has been included in the Top 250 Growth Companies by the Erasmus Centre for Entrepreneurship for two consecutive years.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Benelux and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. They understand the dynamics and opportunities and have an extensive network in these sectors.
Holland Venture start nieuw private equity fonds
Amsterdam, 1 juli 2009 - Holland Venture heeft een nieuw private equity fonds van 70 miljoen euro opgezet dat zich richt op groei- en buy-out investeringen in de Benelux. De doelgroep van het fonds bestaat uit bestaande ondernemingen met een ondernemingswaarde tussen...
Verkoop Orthos Europe BV aan Atrium Innovations Inc.
Amsterdam, 22 september 2008 - Holland Venture heeft vandaag haar meerderheidsbelang in Orthos Europe BV verkocht. Orthos Europe BV houdt 100% van de aandelen van AOV Orthomoleculaire Voedingssupplementen BV, een onderneming die hooggedoseerde voedingssupplementen...
Holland Venture verkoopt haar meerderheidsbelang in Sunday’s International aan het management van de onderneming
Amsterdam, 9 juni 2008 - Holland Venture heeft haar meerderheidsbelang in Sunday’s International verkocht aan het management van de onderneming onder leiding van algemeen directeur Rob Bontje. Holland Venture realiseert hiermee een aantrekkelijk rendement op het...
Holland Venture verkoopt haar aandelen in INS Group S.A.
Amsterdam, 12 september 2007 - Holland Venture is verheugd om u te kunnen melden dat zij haar aandelen in INS Group, een in België gevestigd netwerk and systemen integrator, aan BT verkocht heeft. Met BT is overeengekomen dat zij 100% van de aandelen in INS Group...
Vacature Investment Analyst Healthcare BO
Investment Manager buy-out HealthcareInvestment Manager buy-out Healthcare Sector: Private Equity en Venture Capital Locatie: Amsterdam Opleidingsniveau: WO Over onze organisatie Holland Capital is een succesvolle participatiemaatschappij welke zich richt op...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl